Mammoth Biosciences, Inc., a biotechnology company harnessing its proprietary next-generation CRISPR gene editing platform to create potential one-time curative therapies, today announced new ...

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

( MENAFN - EIN Presswire) The Interventional Cardiovascular Devices market is projected to expand at a CAGR of 4.66%, reaching a market size of USD 69.1 billion by 2032 ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access information on a device and to provide personalised ads and content, ad and ...